Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3%
Generic Name: octinoxate 7.5%, octisalate 5%, oxybenzone 3%
Brand Names:
Purpose Dual Treatment Spf 10
Purpose Sunscreen
Overview
Purpose Sunscreen
Uses
Uses helps prevent sunburn
Dosage
Directions apply generously and evenly 15 minutes before sun exposure apply to all skin exposed to the sun use a water reistant sunscreen if swimming or sweating reapply at least every 2 hours children un 6 months of age: Ask a doctor
Side Effects
When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs
Warnings
Warnings Skin Cancer/Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and ealy skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only Do not use on damaged or broken skin
Frequently Asked Questions
What is Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3% used for?▼
Uses helps prevent sunburn
What are the side effects of Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3%?▼
When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs
What are the important warnings for Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3%?▼
Warnings Skin Cancer/Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and ealy skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only Do not use on damaged or broken skin
Related Medications
Daptomycin
daptomycin
Lipopeptide Antibacterial [EPC]
Treatment of complicated skin and skin structure infections and Staphylococcus aureus bloodstream infections including right-sided endocarditis.
Benzocaine Micronized
benzocaine micronized
Dosage form: POWDER. Active ingredients: BENZOCAINE (1 kg/kg). Category: BULK INGREDIENT.
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
Cytochrome P450 3A Inhibitor [EPC]
11 DESCRIPTION GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) is a fixed-dose combination tablet containing elvitegravir (EVG), cobicistat (COBI), emtricitabine (FTC), and tenofovir alafenamide (TAF) for oral administration. EVG is an HIV-1 integrase strand transfer inhibitor. COBI is a mechanism-based inhibitor of cytochrome P450 (CYP) enzymes of the CYP3A family.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.